$QSEP
QS Energy, Inc.

2023 Q4 Form 10-Q Financial Statement

#000168316823008023 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $55.00K $47.00K
YoY Change -78.76% -63.85%
% of Gross Profit
Depreciation & Amortization $4.000K $0.00
YoY Change 300.0% -100.0%
% of Gross Profit
Operating Expenses $235.0K $47.00K
YoY Change -54.81% -63.85%
Operating Profit -$211.0K
YoY Change -38.66%
Interest Expense -$70.00K -$90.00K
YoY Change -41.18% -3.23%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$305.0K -$300.0K
YoY Change -52.27% -31.35%
Income Tax
% Of Pretax Income
Net Earnings -$305.0K -$301.0K
YoY Change -52.27% -31.12%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 392.5M shares 386.4M shares
Diluted Shares Outstanding 386.6M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.00K $210.0K
YoY Change -47.37% -16.67%
Cash & Equivalents $70.00K $214.0K
Short-Term Investments
Other Short-Term Assets $12.00K $30.00K
YoY Change -36.84% 66.67%
Inventory
Prepaid Expenses $12.00K $25.00K
Receivables
Other Receivables
Total Short-Term Assets $82.00K $239.0K
YoY Change -46.05% -11.48%
LONG-TERM ASSETS
Property, Plant & Equipment $2.000K $3.000K
YoY Change -66.67% -57.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.000K $3.000K
YoY Change -66.67% -97.56%
TOTAL ASSETS
Total Short-Term Assets $82.00K $239.0K
Total Long-Term Assets $2.000K $3.000K
Total Assets $84.00K $242.0K
YoY Change -46.84% -38.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.198M $2.139M
YoY Change 12.03% 12.4%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.158M $2.210M
YoY Change 11.24% 17.8%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.328M $5.283M
YoY Change 9.9% 11.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.328M $5.283M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.328M $5.283M
YoY Change 9.9% 9.72%
SHAREHOLDERS EQUITY
Retained Earnings -$125.4M -$125.1M
YoY Change 0.99% 1.26%
Common Stock $392.6K $389.0K
YoY Change 4.39% 6.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.244M -$5.041M
YoY Change
Total Liabilities & Shareholders Equity $84.00K $242.0K
YoY Change -46.84% -38.42%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$305.0K -$301.0K
YoY Change -52.27% -31.12%
Depreciation, Depletion And Amortization $4.000K $0.00
YoY Change 300.0% -100.0%
Cash From Operating Activities -$139.0K -$190.0K
YoY Change -60.51% -54.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.000K 330.0K
YoY Change -101.72% -46.08%
NET CHANGE
Cash From Operating Activities -139.0K -190.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -4.000K 330.0K
Net Change In Cash -143.0K 140.0K
YoY Change 20.17% -29.65%
FREE CASH FLOW
Cash From Operating Activities -$139.0K -$190.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$139.0K -$190.0K
YoY Change -60.51% -54.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001103795
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29185
dei Entity Registrant Name
EntityRegistrantName
QS ENERGY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2088326
dei Entity Address Address Line1
EntityAddressAddressLine1
23902 FM 2978
dei Entity Address City Or Town
EntityAddressCityOrTown
Tomball
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77375
dei City Area Code
CityAreaCode
(775)
dei Local Phone Number
LocalPhoneNumber
300-7647
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
392519805 shares
CY2023Q3 us-gaap Cash
Cash
214000 usd
CY2022Q4 us-gaap Cash
Cash
133000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
239000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
152000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6000 usd
CY2023Q3 us-gaap Assets
Assets
242000 usd
CY2022Q4 us-gaap Assets
Assets
158000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2139000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1962000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
939000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
946000 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2141000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1865000 usd
CY2023Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
64000 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
75000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5283000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4848000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5283000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4848000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
388975605 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
388975605 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
376074096 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
376074096 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
388977 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
376075 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119631023 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119075925 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125061000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124142000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5041000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158000 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
164000 usd
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
214000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
508000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
504000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
227000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-211000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-344000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-656000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-731000 usd
CY2023Q3 qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
0 usd
CY2022Q3 qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
0 usd
qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
0 usd
qsep Gain On Partial Forgiveness Of Ppp Note Payable
GainOnPartialForgivenessOfPppNotePayable
63000 usd
CY2023Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
90000 usd
CY2022Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
93000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
263000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
241000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-301000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-437000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919000 usd
us-gaap Net Income Loss
NetIncomeLoss
-909000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
386625687 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
386625687 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
361911870 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
361911870 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
383451584 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
383451584 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
358462524 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
358462524 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4979000 usd
CY2023Q3 qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
83000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
128000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
8000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-301000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5041000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
253000 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
231000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5041000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4514000 usd
CY2022Q3 qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
14000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
283000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
208000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-437000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4422000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4173000 usd
qsep Common Stock Issued On Conversion Of Notes Payable
CommonStockIssuedOnConversionOfNotesPayable
20000 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
283000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
306000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000 usd
us-gaap Net Income Loss
NetIncomeLoss
-909000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4422000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919000 usd
us-gaap Net Income Loss
NetIncomeLoss
-909000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
34000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
31000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
90000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
90000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
137000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
115000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000 usd
qsep Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
-0 usd
qsep Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
63000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4000 usd
qsep Increase Decrease In Lease Right Of Use Asset
IncreaseDecreaseInLeaseRightOfUseAsset
0 usd
qsep Increase Decrease In Lease Right Of Use Asset
IncreaseDecreaseInLeaseRightOfUseAsset
27000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
177000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
177000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-7000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-12000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-26000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-491000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-571000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
qsep Proceeds From Issuance Of Convertible Debt And Warrants
ProceedsFromIssuanceOfConvertibleDebtAndWarrants
533000 usd
qsep Proceeds From Issuance Of Convertible Debt And Warrants
ProceedsFromIssuanceOfConvertibleDebtAndWarrants
393000 usd
qsep Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
50000 usd
qsep Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
326000 usd
qsep Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
11000 usd
qsep Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
9000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
572000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
710000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
81000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
138000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
214000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
252000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
qsep Conversion Of Convertible Debentures And Accrued Interest To Common Stock
ConversionOfConvertibleDebenturesAndAccruedInterestToCommonStock
253000 usd
qsep Conversion Of Convertible Debentures And Accrued Interest To Common Stock
ConversionOfConvertibleDebenturesAndAccruedInterestToCommonStock
20000 usd
qsep Value Of Warrants Issued With Convertible Notes
ValueOfWarrantsIssuedWithConvertibleNotes
231000 usd
qsep Value Of Warrants Issued With Convertible Notes
ValueOfWarrantsIssuedWithConvertibleNotes
283000 usd
us-gaap Net Income Loss
NetIncomeLoss
-919000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-491000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5041000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
1977000 usd
CY2023Q3 us-gaap Cash
Cash
214000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
227000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zcGdmTlR9MQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_867_zelolteJjElj">Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accruals for potential liabilities, assumptions used in valuing equity instruments issued for financing and services and realization of deferred tax assets, among others. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81212412 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
90630044 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1510000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1393000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
749000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
612000 usd
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2259000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2005000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
118000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
140000 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2141000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1865000 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
227000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130000 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd

Files In Submission

Name View Source Status
0001683168-23-008023-index-headers.html Edgar Link pending
0001683168-23-008023-index.html Edgar Link pending
0001683168-23-008023.txt Edgar Link pending
0001683168-23-008023-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsenergy_ex3101.htm Edgar Link pending
qsenergy_ex3102.htm Edgar Link pending
qsenergy_ex3200.htm Edgar Link pending
qsenergy_i10q-093023.htm Edgar Link pending
qsep-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
qsep-20230930_cal.xml Edgar Link unprocessable
qsep-20230930_def.xml Edgar Link unprocessable
qsep-20230930_lab.xml Edgar Link unprocessable
qsep-20230930_pre.xml Edgar Link unprocessable
qsenergy_i10q-093023_htm.xml Edgar Link completed
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable